Response: Mechanism of Action of High-Dose Factor VIIa
- 1 January 2003
- journal article
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 23 (1) , 10
- https://doi.org/10.1161/01.atv.0000047646.64969.8b
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Mechanism of factor VIIa–dependent coagulation in hemophilia bloodBlood, 2002
- Response of Factor VIII and IX-Deficient Blood to Wild Type and High Membrane Affinity Mutant Factor VIIa in an In Vitro Whole Blood Clotting Assay: Possible Correlation to Clinical OutcomeThrombosis and Haemostasis, 2002
- Recombinant factor VIIa (NovoSeven®) as a hemostatic agentSeminars in Hematology, 2001
- Relationship between Factor VII Activity and Clinical Efficacy of Recombinant Factor VIIa Given by Continuous Infusion to Patients with Factor VIII InhibitorsThrombosis and Haemostasis, 2001
- Elective Surgery on Factor VIII Inhibitor Patients Using Continuous Infusion of Recombinant Activated Factor VIIThrombosis and Haemostasis, 2001
- Platelets and Phospholipids in Tissue Factor-initiated Thrombin GenerationThrombosis and Haemostasis, 2001
- Platelet activity of high‐dose factor VIIa is independent of tissue factorBritish Journal of Haematology, 1997
- Stroma free human platelet lysates potentiate the in vivo thrombogenicity of factor Xa by the provision of coagulant-active phospholipidBritish Journal of Haematology, 1982
- The coagulant-active phospholipid content is a major determinant of in vivo thrombogenicity of prothrombin complex (Factor IX) concentrates in rabbitsBlood, 1982
- The coagulant-active phospholipid content is a major determinant of in vivo thrombogenicity of prothrombin complex (Factor IX) concentrates in rabbitsBlood, 1982